SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
7689093
Source:
http://linkedlifedata.com/resource/pubmed/id/7689093
Search
Subject
(
55
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0069736
,
umls-concept:C0079459
,
umls-concept:C0920321
pubmed:issue
9
pubmed:dateCreated
1993-9-23
pubmed:abstractText
We performed a phase I trial of piroxantrone with and without granulocyte colony-stimulating factor (G-CSF) to determine whether the use of this cytokine would enable us to increase the dose-intensity of piroxantrone.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8309333
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Anthraquinones
,
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Granulocyte Colony-Stimulating...
,
http://linkedlifedata.com/resource/pubmed/chemical/Pyrazoles
,
http://linkedlifedata.com/resource/pubmed/chemical/oxantrazole
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0732-183X
pubmed:author
pubmed-author:BakerS PSP
,
pubmed-author:BalisF MFM
,
pubmed-author:BerkS HSH
,
pubmed-author:ChouEE
,
pubmed-author:DenicoffA MAM
,
pubmed-author:HilligMM
,
pubmed-author:O'ShaughnessyJ AJA
,
pubmed-author:OttersonG AGA
,
pubmed-author:PoplackD GDG
,
pubmed-author:SavareseD MDM
pubmed:issnType
Print
pubmed:volume
11
pubmed:owner
NLM
pubmed:authorsComplete
N
pubmed:pagination
1795-803
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed-meshheading:7689093-Adult
,
pubmed-meshheading:7689093-Aged
,
pubmed-meshheading:7689093-Anthraquinones
,
pubmed-meshheading:7689093-Antineoplastic Agents
,
pubmed-meshheading:7689093-Bone Marrow Diseases
,
pubmed-meshheading:7689093-Drug Administration Schedule
,
pubmed-meshheading:7689093-Female
,
pubmed-meshheading:7689093-Granulocyte Colony-Stimulating Factor
,
pubmed-meshheading:7689093-Humans
,
pubmed-meshheading:7689093-Logistic Models
,
pubmed-meshheading:7689093-Male
,
pubmed-meshheading:7689093-Middle Aged
,
pubmed-meshheading:7689093-Multivariate Analysis
,
pubmed-meshheading:7689093-Neoplasms
,
pubmed-meshheading:7689093-Pyrazoles
pubmed:year
1993
pubmed:articleTitle
Phase I study of high-dose piroxantrone with granulocyte colony-stimulating factor.
pubmed:affiliation
Medicine Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Clinical Trial, Phase I